Positive cytoplasmic staining for MELK ranged from 3% (1/33) of benign, to 40% (4/10) of DCIS cases, and to 44% (17/39) of IDC cases (p<0.001). This evidence concerns the gene MELK and ductal breast carcinoma in situ.